These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 21122943

  • 21. Detection of contact hypersensitivity to corticosteroids in allergic contact dermatitis patients who do not respond to topical corticosteroids.
    Gönül M, Gül U.
    Contact Dermatitis; 2005 Aug; 53(2):67-70. PubMed ID: 16033397
    [Abstract] [Full Text] [Related]

  • 22. [Corticosteroids and the risk of glaucoma].
    van Boxtel LA, Hardus PL, Al Hassan WS, van Voorst Vader PC, Jansonium NM.
    Ned Tijdschr Geneeskd; 2005 Nov 05; 149(45):2485-9. PubMed ID: 16304883
    [Abstract] [Full Text] [Related]

  • 23. Ocular complications in recipients of kidney transplants.
    Blomdahl S, Calissendorff B, Magnusson G.
    Scand J Urol Nephrol Suppl; 1977 Nov 05; (42):195-7. PubMed ID: 356209
    [Abstract] [Full Text] [Related]

  • 24. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF, Calvieri S, Ortonne JP, Ho VC, Weise-Riccardi S, Barbier N, Paul CF.
    Br J Dermatol; 2007 Nov 05; 157(5):954-9. PubMed ID: 17935515
    [Abstract] [Full Text] [Related]

  • 25. Percutaneous absorption of potent topical corticosteroids in patients with severe atopic dermatitis.
    van Velsen SG, Haeck IM, Bruijnzeel-Koomen CA.
    J Am Acad Dermatol; 2010 Nov 05; 63(5):911-3. PubMed ID: 20950744
    [No Abstract] [Full Text] [Related]

  • 26. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption.
    Pariser D.
    Am J Ther; 2009 Nov 05; 16(3):264-73. PubMed ID: 19262357
    [Abstract] [Full Text] [Related]

  • 27. StabiEL: stabilization of skin condition with Elidel--a patients' satisfaction observational study addressing the treatment, with pimecrolimus cream, of atopic dermatitis pretreated with topical corticosteroid.
    Gollnick H, Luger T, Freytag S, Bräutigam M, STABIEL study group.
    J Eur Acad Dermatol Venereol; 2008 Nov 05; 22(11):1319-25. PubMed ID: 18540990
    [Abstract] [Full Text] [Related]

  • 28. Corticosteroids' effect on the height of atopic dermatitis patients: a controlled questionnaire study.
    Thomas MW, Panter AT, Morrell DS.
    Pediatr Dermatol; 2009 Nov 05; 26(5):524-8. PubMed ID: 19840305
    [Abstract] [Full Text] [Related]

  • 29. Glaucoma caused by topical corticosteroid application to the eyelids.
    Chan HH, Salmon JF.
    Med J Aust; 2019 Mar 05; 210(4):152-153.e1. PubMed ID: 30773632
    [No Abstract] [Full Text] [Related]

  • 30. NEWER TOPICAL CORTICOSTEROIDS. A PAIRED COMPARISON STUDY OF TRIAMCINOLONE ACETONIDE AND FLUOCINOLONE ACETONIDE.
    ORENTREICH N, BERGER R.
    Curr Ther Res Clin Exp; 1963 Aug 05; 5():422-5. PubMed ID: 14057778
    [No Abstract] [Full Text] [Related]

  • 31. Topical corticosteroids and cataract.
    Munjal VP, Dhir SP, Jain IS, Gangwar DN, D'Souza M.
    Indian J Ophthalmol; 1984 Aug 05; 32(6):478-80. PubMed ID: 6599888
    [No Abstract] [Full Text] [Related]

  • 32. Inhaled corticosteroids and the risk of cataracts.
    Whitmore SE.
    N Engl J Med; 1997 Nov 20; 337(21):1554; author reply 1555. PubMed ID: 9380122
    [No Abstract] [Full Text] [Related]

  • 33. [Ocular side-effects of corticotherapy (analysis of 3 cases)].
    Ndiaye PA, Ndiaye MR, Ceccon JF, Wade A.
    Dakar Med; 1989 Nov 20; 34(1-4):161-5. PubMed ID: 2491377
    [Abstract] [Full Text] [Related]

  • 34. Case report: visual loss caused by facial steroids.
    Michaeli-Cohen A, Neudorfer M, Loewenstein A, Lazar M, Geyer O.
    Can Fam Physician; 1998 Nov 20; 44():2462-3. PubMed ID: 9839064
    [No Abstract] [Full Text] [Related]

  • 35. [Corticosteroid phobia in patients with atopic dermatitis].
    Jenerowicz D, Czarnecka-Operacz M, Silny W.
    Wiad Lek; 2005 Nov 20; 58(11-12):607-15. PubMed ID: 16594469
    [Abstract] [Full Text] [Related]

  • 36. Risk of cataract among users of intranasal corticosteroids.
    Derby L, Maier WC.
    J Allergy Clin Immunol; 2000 May 20; 105(5):912-6. PubMed ID: 10808171
    [Abstract] [Full Text] [Related]

  • 37. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
    Neumann E, Amtage D, Bruckner-Tuderman L, Mockenhaupt M.
    J Dtsch Dermatol Ges; 2008 Jul 20; 6(7):548-53. PubMed ID: 18248495
    [Abstract] [Full Text] [Related]

  • 38. Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.
    Luger TA, Lahfa M, Fölster-Holst R, Gulliver WP, Allen R, Molloy S, Barbier N, Paul C, Bos JD.
    J Dermatolog Treat; 2004 Jun 20; 15(3):169-78. PubMed ID: 15204150
    [Abstract] [Full Text] [Related]

  • 39. Down-regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis.
    Yawalkar N, Karlen S, Egli F, Brand CU, Graber HU, Pichler WJ, Braathen LR.
    J Allergy Clin Immunol; 2000 Nov 20; 106(5):941-7. PubMed ID: 11080718
    [Abstract] [Full Text] [Related]

  • 40. Topical treatment of atopic dermatitis.
    Boguniewicz M.
    Immunol Allergy Clin North Am; 2004 Nov 20; 24(4):631-44, vi-vii. PubMed ID: 15474863
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.